GAS5 and lip and oral cavity carcinoma: The above evidence suggests a complex role of GAS5 in the clinical course of oral cancer rather than an absolutely positive or negative role, and such an effect may be altered by specified SNPs and environment factors since both of them can influence the clinical presentation of oral cancer [37,38,44].